These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37454168)

  • 21. Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson's disease: a clinical-instrumental study.
    Cavallieri F; Campanini I; Gessani A; Budriesi C; Fioravanti V; Di Rauso G; Feletti A; Damiano B; Scaltriti S; Guagnano N; Bardi E; Corni MG; Rossi J; Antonelli F; Cavalleri F; Molinari MA; Contardi S; Menozzi E; Puzzolante A; Vannozzi G; Bergamini E; Pavesi G; Meoni S; Fraix V; Fraternali A; Versari A; Lusuardi M; Biagini G; Merlo A; Moro E; Valzania F
    J Neurol; 2023 Sep; 270(9):4342-4353. PubMed ID: 37208527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?
    Fabbri M; Zibetti M; Ferrero G; Accornero A; Guimaraes I; Rizzone MG; Romagnolo A; Ferreira JJ; Lopiano L
    Parkinsonism Relat Disord; 2019 Jul; 64():242-248. PubMed ID: 31060986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients.
    Li J; Zhang Y; Li Y
    Br J Neurosurg; 2015 Jun; 29(3):329-33. PubMed ID: 25812021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson's disease.
    Hammer MJ; Barlow SM; Lyons KE; Pahwa R
    J Commun Disord; 2011; 44(1):37-48. PubMed ID: 20708741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic deep brain stimulation aggravates speech problems in Parkinson's disease: Objective and subjective analysis of the influence of stimulation frequency and electrode contact location.
    Phokaewvarangkul O; Boonpang K; Bhidayasiri R
    Parkinsonism Relat Disord; 2019 Sep; 66():110-116. PubMed ID: 31327627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Speech changes induced by deep brain stimulation of the subthalamic nucleus in Parkinson disease: involvement of the dentatorubrothalamic tract.
    Fenoy AJ; McHenry MA; Schiess MC
    J Neurosurg; 2017 Jun; 126(6):2017-2027. PubMed ID: 27611200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Parkinson's disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses.
    Georgiev D; Dirnberger G; Wilkinson L; Limousin P; Jahanshahi M
    Exp Brain Res; 2016 Apr; 234(4):1133-43. PubMed ID: 26758720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term follow-up in advanced Parkinson's disease treated with DBS of the subthalamic nucleus.
    Volonté MA; Clarizio G; Galantucci S; Scamarcia PG; Cardamone R; Barzaghi LR; Falautano M; Mortini P; Comi G; Filippi M
    J Neurol; 2021 Aug; 268(8):2821-2830. PubMed ID: 33598766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A Clinical Study of Patients with Primary Parkinson's Disease Undergoing Bilateral Deep Brain Stimulation (STN-DBS) Surgery in the Subthalamic Nucleus under General Anesthesia].
    Shi YF; Zhang Y; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):583-587. PubMed ID: 35871727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease.
    Blahak C; Wöhrle JC; Capelle HH; Bäzner H; Grips E; Weigel R; Hennerici MG; Krauss JK
    J Neurol; 2007 Feb; 254(2):169-78. PubMed ID: 17334951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric STN DBS for FOG in Parkinson's disease: A pilot trial.
    Meoni S; Debȗ B; Pelissier P; Scelzo E; Castrioto A; Seigneuret E; Chabardes S; Fraix V; Moro E
    Parkinsonism Relat Disord; 2019 Jun; 63():94-99. PubMed ID: 30826266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease. Five years' personal experience.
    Zabek M; Sobstyl M; Koziara H; Kadziołka B; Mossakowski Z; Dzierzecki S
    Neurol Neurochir Pol; 2010; 44(1):3-12. PubMed ID: 20358480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    Choi JH; Kim HJ; Lee JY; Yoo D; Im JH; Paek SH; Jeon B
    PLoS One; 2019; 14(8):e0221219. PubMed ID: 31454366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.